These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24304285)

  • 1. HIV-antigens charged on phosphorus dendrimers as tools for tolerogenic dendritic cells-based immunotherapy.
    Vacas-Córdoba E; Bastida H; Pion M; Hameau A; Ionov M; Bryszewska M; Caminade AM; Majoral JP; Muñoz-Fernández MÁ
    Curr Med Chem; 2014; 21(16):1898-909. PubMed ID: 24304285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycodendrimers as new tools in the search for effective anti-HIV DC-based immunotherapies.
    Córdoba EV; Pion M; Rasines B; Filippini D; Komber H; Ionov M; Bryszewska M; Appelhans D; Muñoz-Fernández MA
    Nanomedicine; 2013 Oct; 9(7):972-84. PubMed ID: 23506949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.
    Vacas-Córdoba E; Climent N; De La Mata FJ; Plana M; Gómez R; Pion M; García F; Muñoz-Fernández MÁ
    Nanomedicine (Lond); 2014 Dec; 9(17):2683-702. PubMed ID: 25529571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Several HIV Antigens Simultaneously Loaded with G2-NN16 Carbosilane Dendrimer in the Cell Uptake and Functionality of Human Dendritic Cells.
    Sepúlveda-Crespo D; Vacas-Córdoba E; Márquez-Miranda V; Araya-Durán I; Gómez R; Mata FJ; González-Nilo FD; Muñoz-Fernández MÁ
    Bioconjug Chem; 2016 Dec; 27(12):2844-2849. PubMed ID: 27998072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
    Waeckerle-Men Y; Scandella E; Uetz-Von Allmen E; Ludewig B; Gillessen S; Merkle HP; Gander B; Groettrup M
    J Immunol Methods; 2004 Apr; 287(1-2):109-24. PubMed ID: 15099760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
    da Silva LT; Santillo BT; de Almeida A; Duarte AJDS; Oshiro TM
    Front Immunol; 2018; 9():2993. PubMed ID: 30619346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus dendrimers as carriers of siRNA--characterisation of dendriplexes.
    Ferenc M; Pedziwiatr-Werbicka E; Nowak KE; Klajnert B; Majoral JP; Bryszewska M
    Molecules; 2013 Apr; 18(4):4451-66. PubMed ID: 23591925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer.
    Pion M; Serramia MJ; Diaz L; Bryszewska M; Gallart T; García F; Gómez R; de la Mata FJ; Muñoz-Fernandez MÁ
    Biomaterials; 2010 Nov; 31(33):8749-58. PubMed ID: 20832111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial.
    Ide F; Nakamura T; Tomizawa M; Kawana-Tachikawa A; Odawara T; Hosoya N; Iwamoto A
    J Med Virol; 2006 Jun; 78(6):711-8. PubMed ID: 16628588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral high-generation phosphorus dendrimers inhibit macrophage-mediated inflammatory response in vitro and in vivo.
    Posadas I; Romero-Castillo L; El Brahmi N; Manzanares D; Mignani S; Majoral JP; Ceña V
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7660-E7669. PubMed ID: 28847956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation.
    Bürdek M; Spranger S; Wilde S; Frankenberger B; Schendel DJ; Geiger C
    J Transl Med; 2010 Sep; 8():90. PubMed ID: 20920165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
    Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y
    Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.
    Cobb A; Roberts LK; Palucka AK; Mead H; Montes M; Ranganathan R; Burkeholder S; Finholt JP; Blankenship D; King B; Sloan L; Harrod AC; Lévy Y; Banchereau J
    J Immunol Methods; 2011 Feb; 365(1-2):27-37. PubMed ID: 21093448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection.
    Fan Z; Huang XL; Zheng L; Wilson C; Borowski L; Liebmann J; Gupta P; Margolick J; Rinaldo C
    J Immunol; 1997 Nov; 159(10):4973-82. PubMed ID: 9366424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour antigen-loaded mouse dendritic cells maturing in the presence of inflammatory cytokines are potent activators of immune response in vitro but not in vivo.
    Rossowska J; Pajtasz-Piasecka E; Szyda A; Krawczenko A; Zietara N; Dus D
    Oncol Rep; 2009 Jun; 21(6):1539-49. PubMed ID: 19424635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell vaccine design: strategies for eliciting peripheral tolerance as therapy of autoimmune diseases.
    Xiao BG; Huang YM; Link H
    BioDrugs; 2003; 17(2):103-11. PubMed ID: 12641489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
    Dullaers M; Thielemans K
    J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses.
    Climent N; García I; Marradi M; Chiodo F; Miralles L; Maleno MJ; Gatell JM; García F; Penadés S; Plana M
    Nanomedicine; 2018 Feb; 14(2):339-351. PubMed ID: 29157976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorus dendrimers for nanomedicine.
    Caminade AM
    Chem Commun (Camb); 2017 Aug; 53(71):9830-9838. PubMed ID: 28745767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.